[Evaluation of antitumor activity of etoposide administered orally for 21 consecutive days against human uterine cancer subcutaneous and/or orthotopic xenografts in nude mice].

Matsumoto, S; Mashiba, H; Okamoto, K; Ekimoto, H

[Evaluation of antitumor activity of etoposide administered orally for 21 consecutive days against human uterine cancer subcutaneous and/or orthotopic xenografts in nude mice].

Matsumoto, S; Mashiba, H; Okamoto, K; Ekimoto, H.

Affiliation

Matsumoto S; Anticancer Drugs Dept., Nippon Kayaku Co., Ltd.

Gan To Kagaku Ryoho ; 26(9): 1313-20, 1999 Aug.

Article in Ja | MEDLINE | ID: mdl-10478185

Subject(s)

Antineoplastic Agents, Phytogenic/therapeutic use; Carcinoma, Squamous Cell/drug therapy; Etoposide/therapeutic use; Uterine Neoplasms/drug therapy; Adenocarcinoma/drug therapy; Administration, Oral; Animals; Antineoplastic Agents/therapeutic use; Antineoplastic Agents, Phytogenic/administration & dosage; Camptothecin/analogs & derivatives; Camptothecin/therapeutic use; Carcinoma, Squamous Cell/pathology; Cisplatin/therapeutic use; Etoposide/administration & dosage; Female; Floxuridine/therapeutic use; Humans; Irinotecan; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Skin/pathology; Transplantation, Heterologous; Uterine Neoplasms/pathology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uterine Neoplasms / Carcinoma, Squamous Cell / Etoposide / Antineoplastic Agents, Phytogenic Limits: Animals / Female / Humans Language: Ja Journal: Gan To Kagaku Ryoho Year: 1999 Document type: Article Country of publication: Japan

Search on Google

Add to My VHL

XML

PubMed Links